EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Pathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk

Jose Marcos Sanches, Li Na Zhao iD, Albert Salehi iD, Claes B Wollheim iD, Philipp Kaldis iD

The FEBS Journal · 2023-02 · 290 (3) · 620-648

DOI: 10.1111/febs.16306 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The FEBS Journal, online erschienen am 09.12.2021. Verfasst von Jose Marcos Sanches und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Lund University, Malmö, Sweden. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Insulin Resistance. Die Arbeit wurde bisher 109-mal zitiert (Crossref) und nennt 309 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Faculty of Medicine, Swedish Research Council, Lund University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes is a complex and multifactorial disease that affects millions of people worldwide, reducing the quality of life significantly, and results in grave consequences for our health care system. In type 2 diabetes (T2D), the lack of β‐cell compensatory mechanisms overcoming peripherally developed insulin resistance is a paramount factor leading to disturbed blood glucose levels and lipid metabolism. Impaired β‐cell functions and insulin resistance have been studied extensively resulting in a good understanding of these pathways but much less is known about interorgan crosstalk, which we define as signaling between tissues by secreted factors. Besides hormones and organokines, dysregulated blood glucose and long‐lasting hyperglycemia in T2D is associated with changes in metabolism with metabolites from different tissues contributing to the development of this disease. Recent data suggest that metabolites, such as lipids including free fatty acids and amino acids, play important roles in the interorgan crosstalk during the development of T2D. In general, metabolic remodeling affects physiological homeostasis and impacts the development of T2D. Hence, we highlight the importance of metabolic interorgan crosstalk in this review to gain enhanced knowledge of the pathophysiology of T2D, which may lead to new therapeutic approaches to treat this disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Insulin ResistanceHumansBlood GlucoseQuality of LifeAmino Acids

Stichwörter der Autor:innen

diabetesfree fatty acidsinflammationinterorgan crosstalklivermetabolitesmetabolomicsorganokinestype 2 diabetes

Substanzen

Blood GlucoseAmino Acids

Autor:innen und Institutionen

  • Department of Clinical Sciences, Lund University, Malmö, Sweden.
  • Department of Cell Physiology and Metabolism, University of Geneva, Geneva, Switzerland.

ORCID-Profile: Li Na Zhao, Albert Salehi, Claes B Wollheim, Philipp Kaldis

Förderung

  • Faculty of Medicine
  • Swedish Research Council
  • Lund University
  • Swedish Foundation for Strategic Research
  • Swedish Diabetes Foundation
  • IngaBritt och Arne Lundbergs Forskningsstiftelse

Zitieren

APA

Sanches, J. M., Zhao, L. N., Salehi, A., Wollheim, C. B., & Kaldis, P. (2023). Pathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk. The FEBS Journal, 290(3), 620-648. https://doi.org/10.1111/febs.16306

Vancouver

Sanches JM, Zhao LN, Salehi A, Wollheim CB, Kaldis P. Pathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk. The FEBS Journal. 2023;290(3):620-648. doi:10.1111/febs.16306

BibTeX
@article{Sanches2023,
  author = {Sanches, Jose Marcos and Zhao, Li Na and Salehi, Albert and Wollheim, Claes B and Kaldis, Philipp},
  title = {Pathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk},
  journal = {The FEBS Journal},
  year = {2023},
  volume = {290},
  number = {3},
  pages = {620--648},
  doi = {10.1111/febs.16306}
}
Kostenlos starten →